NCT05547919View on ClinicalTrials.gov

PSMA in Gastroenterologic Tumors (GIPSMA)

NARecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions
Gastrointestinal Cancer
Interventions
RADIATION

18F-PSMA PET/CT

Patients with metastasized gastroenterologic tumors, that exhibit histological PSMA expression, receive an additional 18F-PSMA PET/CT to routine imaging.

Trial Locations (1)

97080

RECRUITING

University Hospital Wuerzburg, Würzburg

All Listed Sponsors
lead

Wuerzburg University Hospital

OTHER